GLI1 and neoplasm: Using an in vivo genetic mouse model that reflects the changes in stromal content of human PCa, however, we found that aberrant activation of HH signaling in the Gli1-expressing subset of stromal cells in PB-MYC tumors results in decreased tumor progression, revealing that tumor stroma can restrain PCa progression.